BioInvent International Aktiebolag
556537-7263ActiveClinical-stage company developing novel immuno-oncology antibody therapeutics for cancer.
Oversikt
- 100–199
- Ansatte
- 20–50mill SEK
- Omsetning
- 1997
- Grunnlagt
Nøkkelbeslutningstakere
Cecilia Hofvander
VP Investor Relations
Thomas Hecht
Member of the Board
Andres McAllister
Chief Medical Officer
Kristoffer Bissessar
Member of the Board
+18 flere kontakter i Funnelfeedr
Beskrivelse
BioInvent is a clinical-stage biotechnology company focused on discovering and developing innovative antibody therapeutics for cancer treatment. The core of their work lies in leveraging deep expertise in immunology, cancer biology, and antibody biology to generate novel immuno-oncology drug candida...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Bioteknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE556537726301
Beslutningstakere
22 kontakter i FunnelfeedrCecilia Hofvander
VP Investor Relations
Thomas Hecht
Member of the Board
Andres McAllister
Chief Medical Officer
Kristoffer Bissessar
Member of the Board
Leonard Kruimer
Chairman of the Board
Martin Welschof
Chief Executive Officer
Kristoffer Rudenholm Hansson
Senior Vice President, Technical Operations
Natalie Berner
Member of the Board
Laura Lassouw-Polman
Member of the Board
Bernd Seizinger
Member of the Board
Sylvie Ryckebusch
Chief Business Officer
Stefan Ericsson
Chief Financial Officer
Ashley Robinson
Senior Vice President Strategy & Finance
Björn Frendéus
Chief Scientific Officer
Anette Mårtensson
Employee deputy, Member of the Board
Nanna Lüneborg
Member of the Board
Marina Mangold
Data Protection Officer
Emma Meurling
HR Director
Ingunn Munch Lindvig
Senior Vice President Regulatory Affairs
Andre kontakter
Mona Welschof
Clinical Operations
Tomas Wall
Employee Representative
Elin Birgersson
Employee Representative
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrAlligator Bioscience AB
10–19 ansatteClinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
CAEDO ONCOLOGY AS
Developing novel monoclonal antibodies for targeted cancer immunotherapy treatment.
Active Biotech AB (publ)
1–4 ansatteDeveloping novel treatments for cancer and inflammatory eye diseases.
Affibody AB
50–99 ansatteDeveloping next-generation radiopharmaceuticals using proprietary Affibody technology.
Respiratorius AB (publ)
Developing novel drugs to treat aggressive lymphoma cancers.
Utforsk mer
Spørsmål om BioInvent International Aktiebolag
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo